NanoMed · Nanoporous and Nanostructured Materials for Medical Applications
Horizon 2020 — Marie Skłodowska-Curie Actions
- Duration
- 2017-01-01 → 2022-10-31
- EU contribution
- €972,000
- Participants
- 13
- Scheme
- MSCA-RISE
Lines connect the coordinator with its partners.
Results in brief
Nanoporous and Nanostructured Materials for Medical Applications
This project aims to develop novel nanostructured adsorbents for the treatment of very serious health conditions associated with acute and chronic exposure to external radiation and uptake of heavy metal and radiation as a consequence of accidental, occupational and deliberate activities and events. or Exposure to radiation and uptake of heavy metals decreases the quality of life in humans. Taking into account that this is a worldwide problem, it is urgent to mitigate it through the development of a novel, low cost and efficient technology able to adsorb and remove these toxic species, or those created through side reactions, from the human body. This is specially important for countries such as Ukraine and Kazakhstan (large areas in the Chernobyl zone and around the Semipalatinsk nuclear test site) that contain important radioactive contamination. Overall, the objectives of the project are: Ø Synthesis and design of nanostructured carbonic sorbents with controlled chemical reactivity, particle size and porosity; Ø Use of nanostructured materials as powerful and safe adsorbents to remove target substances for enterosorbent application Ø Combining different materials and substances in a composite or hybrid system creating an unusual synergy of useful physicochemical and biochemical properties that cannot be achieved in a single- component material Ø Cross-fertilisation between different technologies used to manufacture materials with the same or similar chemical composition (for example, different methods of synthesis of porous gels/cryogels, activated carbon materials, inorganic minerals), bioactive additives, etc.
Data: CORDIS, © European Union
Project objective
This project aims to stimulate intersectoral and international collaboration within Europe and with an ICPC country, Kazakhstan, in the area of novel nanoporous and nanostructured adsorbents for the treatment of very serious health conditions associated with acute and chronic exposure to external radiation and uptake of heavy metals and radiation as a consequence of accidental, occupational or deliberate activities and events. This can dramatically lower the quality of life of the people affected and at present the treatment available is costly and inefficient. Radioactive contamination is a particularly serious problem in two of the countries participating in this project, namely, Ukraine and Kazakhstan, on large territories of the Chernobyl zone and around Semipalatinsk nuclear test site, respectively. A large number of people are affected by living in the areas with elevated level of radioactivity with uncertain long-term consequences to their health and the health of future generations. The expected impact of the project results is development of efficient and cost-effective methods of protection of first responders, population and cancer patients treated with radiotherapy from elevated doses of external and incorporated radiation and for occupational health protection of personnel working and the population living in areas contaminated with heavy metals.
Original text from CORDIS.
Participants
- UNIVERSIDAD DE ALICANTE · AlicanteCoordinatorSpain
- ARISTOTELIO PANEPISTIMIO THESSALONIKIS · THESSALONIKIGreece
- BUDAPESTI MUSZAKI ES GAZDASAGTUDOMANYI EGYETEM · BudapestHungary
- ECOSORBENT LIMITED LIABILITY COMPANY · CHISINAUMoldova
- INSTITUT MAX VON LAUE - PAUL LANGEVIN · GrenobleFrance
- INSTITUTE OF COMBUSTION PROBLEMS SCIENTIFIC COMMITTEE OF THE MINISTRYOF EDUCATION AND SCIENCE OF THE REPUBLIC OF KAZAKHSTAN · AlmatyKazakhstan
- INSTITUTUL DE CHIMIE · CHISINAUMoldova
- NAZARBAYEV UNIVERSITY · AstanaKazakhstan
- NOVA ID FCT - ASSOCIACAO PARA A INOVACAO E DESENVOLVIMENTO DA FCT · CaparicaPortugal
- Pharmidex Pharmaceutical Services Limited · LondonUnited Kingdom
- R.E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY, ONCOLOGY AND RADIOBIOLOGY OF NATIONAL ACADEMY OF SCIENCES OF UKRAINE · KYIVUkraine
- TOV NAUKOVO VYROBNICHE PIDRIEMSTVOTEHNOLOGIKA · KYIVUkraine
- USTAV GEOTECHNIKY SLOVENSKEJ AKADEMIE VIED · Kosice SeverSlovakia
Links
- View on CORDIS
- DOI: 10.3030/734641
- https://arquivo.pt/wayback/20220528060400/http://www.nanomed-project.eu/
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5c925c042&appId=PPGMS
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5f3691c6b&appId=PPGMS
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5f6bdb49a&appId=PPGMS
- https://projects.research-and-innovation.ec.europa.eu/en/projects/success-stories/all/new-way-treat-radiation-sickness
- https://www.ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5b211cd4c&appId=PPGMS
- https://www.ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5bf8a9eb6&appId=PPGMS
- https://www.ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5c12130ad&appId=PPGMS
Data: CORDIS, © European Union
